5-year outcome of initial treatment with ranibizumab monotherapy for polypoidal choroidal vasculopathy with good visual acuity

被引：0
|
作者：
Kohno, Takeya [1 ]
Yamamoto, Manabu [1 ]
Tamachi, Tomoko [1 ]
Asai, Jyunji [1 ]
Oishi, Natsuko [1 ]
Ataka, Shinsuke [1 ]
Yasui, Ayako [1 ]
Cho, Akira [2 ]
Hirabayashi, Michiko [2 ]
Shiraki, Kunihiko [1 ]
机构：
[1] Osaka City Univ, Grad Sch Med, Ophthalmol & Visual Sci, Osaka, Japan
[2] Shiraniwa Hosp, Ikoma, Japan
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
880
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
    Mori, Ryusaburo
    Yuzawa, Mitsuko
    Akaza, Eriko
    Haruyama, Miho
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2013, 57 (04) : 365 - 371
  • [2] Treatment results at 1 year of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good visual acuity
    Ryusaburo Mori
    Mitsuko Yuzawa
    Eriko Akaza
    Miho Haruyama
    Japanese Journal of Ophthalmology, 2013, 57 : 365 - 371
  • [3] Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity
    Mori, Ryusaburo
    Tanaka, Koji
    Yuzawa, Mitsuko
    MEDICINE, 2018, 97 (25)
  • [4] Outcomes of polypoidal choroidal vasculopathy treated with ranibizumab monotherapy
    Tan, Colin S. H.
    Ngo, Wei Kiong
    Lim, Louis W.
    Cheong, Kai Xiong
    Lim, Tock Han
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2013, 97 (10) : 1357 - 1358
  • [5] Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results
    Joo Young Kim
    Woo Young Son
    Rae Young Kim
    Mirinae Kim
    Young Gun Park
    Young-Hoon Park
    Scientific Reports, 11
  • [6] Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results
    Kim, Joo Young
    Son, Woo Young
    Kim, Rae Young
    Kim, Mirinae
    Park, Young Gun
    Park, Young-Hoon
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [7] Pachychoroid-phenotype effects on 5-year visual outcomes of anti-VEGF monotherapy in polypoidal choroidal vasculopathy
    Shimizu, Yuichiro
    Miyata, Manabu
    Ooto, Sotaro
    Miyake, Masahiro
    Mori, Yuki
    Tamura, Hiroshi
    Ueda-Arakawa, Naoko
    Uji, Akihito
    Muraoka, Yuki
    Takahashi, Ayako
    Wakazono, Tomotaka
    Yamashiro, Kenji
    Hata, Masayuki
    Tsujikawa, Akitaka
    ACTA OPHTHALMOLOGICA, 2022, 100 (04) : E943 - E949
  • [8] Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy
    Yoneda, Ai
    Wakiyama, Harumi
    Kurihara, Junko
    Kitaoka, Takashi
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (06) : 1473 - 1479
  • [9] Treatment Outcomes in Eyes with Polypoidal Choroidal Vasculopathy with Poor Baseline Visual Acuity
    Kim, Jae Hui
    Kim, Jong Woo
    Lee, Tae Gon
    Lew, Young Ju
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 31 (04) : 241 - 247
  • [10] Real world experience of the treatment outcome between photodynamic therapy combined with ranibizumab and aflibercept monotherapy in polypoidal choroidal vasculopathy
    Ma, I-Hsin
    Hsia, Yun
    Hsieh, Yi-Ting
    Ho, Tzyy-Chang
    Lai, Tso-Ting
    Yang, Chung-May
    Yang, Chang-Hao
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345